Induction of mucosal antibody responses by microsphere-encapsulated formalin-inactivated simian immunodeficiency virus in a male urethral challenge model

Vaccine

Volumn 17, Issue 22, 1999, Pages 2817-2825

  Ishizaka, Sally T ^a   Israel, Zimra R ^a   Gettie, Agegnehu ^b   Mishkin, Eric M ^a   Staas, Jay K ^c   Gilley, Richard M ^c   Dailey, Peter J ^d   Montefiori, David C ^e   Marx, Preston A ^b,f   Eldridge, John H ^a  

^a PFIZER INC   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c SOUTHERN RESEARCH INSTITUTE   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f TULANE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Microsphere; SIV; Urethral; Vaccine

Indexed keywords

FORMALDEHYDE; IMMUNOGLOBULIN A; INACTIVATED VIRUS VACCINE; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; IMMUNIZATION; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRATRACHEAL DRUG ADMINISTRATION; MALE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; URETHRA; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; FORMALDEHYDE; IMMUNITY, MUCOSAL; MACACA MULATTA; MALE; MICROSPHERES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TIME FACTORS; URETHRAL DISEASES; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 0033575489     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00093-6     Document Type: Article

References (35)

1. Clements J.E., Zink M.C. Molecular biology and pathogenesis of animal lentivirus infections. Clin Microbiol Rev. 9:1996;100-117.
2. Johnson R.P. Macaque models for AIDS vaccine development. Current Opinion Immunol. 8:1996;554-560.
3. Warren J.T., Levinson M.A. Fourth annual survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates. J Med Primatol. 24:1995;150-168.
4. Hu S.-L., Polacino P., Stallard V., J. Klaniecki V., Pennathur S., Travis B.M., Misher L., Kornas H., Langlois A.J., Morton W.R., Benveniste R.E. Recombinant subunit vaccines as an approach to study correlates of protection against primate lentivirus infection. Immunol Lett. 51:1996;115-119.
5. + cytotoxic T lymphocytes. Science. 252:1991;440-442.
6. Daniel M.D., Mazzara G.P., Simon M.A., Sehgal P.K., Kodama T., Panicali D.L., Desrosiers R.C. High-titer immune responses elicited by recombinant vaccinia virusting are ineffective in preventing virulent SIV infection. AIDS Res Human Retrovirol. 10:1991;839-851.
7. + cytotoxic T lymphocytes. J Exp Med. 176:1992;1739-1744.
8. Eldridge J.H., Gilley R.M., Staas J.K., Moldoveanu Z., Meulbroek J.A., Tice T.R. Biodegradable microspheres: vaccine delivery system for oral immunization. Current Topics Microbiol Immunol. 146:1989;59-66.
9. Takao S.I., Kiyotani K., Sakaguchi T., Fujii Y., Seno M., Yoshida T. Protection of mice from respiratory Sendai virus infections by recombinant vaccinia viruses. J Virol. 71:1997;832-838.
10. Gallichan W.S., Rosenthal K.L. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine. 13:1995;1589-1595.
11. Marx P.A., Compans R.W., Gettie A., Staas J.K., Gilley R.M., Mulligan M.J., Yamshchikov G.V., Chen D., Eldridge J.H. Protection against vaginal SIV transmission with microencapsulated vaccine. Science. 260:1993;1323-1327.
12. Pachl C., Todd J., Kern D., Sheridan P., Fong S., Stempien M., Hoo B., Besemer D., Yeghiazarian T., Irvine B., et al. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J AIDS Human Retrovirol. 8:(5):1995;446-454.
13. Dailey P, Zamroud M, Kelso R, Kolberg J, Urdea M. Quantitation of simian immunodeficiency virus (SIV) RNA in plasma of acute and chronically infected rhesus macaques using a branched DNA (bDNA) signal amplification assay. Abstract 99, 13th Annual Symposium on Nonhuman Primate Models of AIDS, Montery, CA, November 5-6, 1995.
14. Pachl C., Todd J.A., Kern D.J., Sheridan S.-J., Fong M., Stempein B., Hoo B., Besemer D., Yeghiazarian T., Irvine B., Kolberg J., Kokka R., Neuwald P., Urdea M.S. Rapid and prescise quantification of HIV-1 RNA in plasma using branched DNA signal amplification assay. J AIDS and Human Retrovirol. 8:1995;446-454.
15. Miller C., Alexander N., Sujipto S., Lackner A., Gettie A., Hendrickx A., Lowenstine L., Jennings M., Marx P. Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J Virol. 63:1989;4277-4284.
16. Montefiori D., Baba T., Li A., Bilska M., Ruprecht R. Neutralizing and infection-enhancing antibody responses do not correlate with the differential pathogenicity of SIVmac239Δ3 in adult and infant rhesus monkeys. J Immunol. 157:1996;5528-5535.
17. Childers N.K., Denys F.R., McGee N.F., Michalek S.M. Ultrastructural study of liposome uptake by M cells of rat Peyer's patch: an oral vaccine system for delivery of purified antigen. Regional Immunology. 3:1990;8-16.
18. Gould-Fogerite S., Edghill-Smith Y., Kheiri M., Wang Z., Das K., Feketeova E., Canki M., Mannino R.J. Lipid matrix-based subunit vaccines: a structure-function approach to oral and parenteral immunization. AIDS Res Hum Retroviruses. 10:1994;S99-S103.
19. Hanes J., Chiba M., Langer R. Polymer microspheres for vaccine delivery. Powell M.F., Newman M.J. Vaccine design: the subunit and adjuvant approach. 1995;389-412 Plenum Press, New York.
20. Eldridge J.H., Staas J.K., Chen D., Marx P.A., Tice T.R., Gilley R.M. New advances in vaccine delivery systems. Sem Hematol. 30:1993;16-24.
21. Thapar M.A., Parr E.L., Parr M.B. Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization. Immunology. 70:1990;121-125.
22. Johansson E.L., Rask C., Fredriksson M., Eriksson K., Czerkinsky C., Holmgren J. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect Immun. 66:1998;514-520.
23. Pudney J., Anderson D.J. Immunobiology of the human penile urethra. Am J Pathol. 147:1995;155-165.
24. Wyand M.S., Manson K.H., Garcia-Moll M., Montefiori D., Desrosiers R.C. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J Virol. 70:1996;3724-3733.
25. Langlois A.J., Desrosiers R., Lewis M.G., Kewalramani V.N., Littman D.R., Zhou J.Y., Manson K., Wyand M.S., Bolognesi D.P., Montefiori D.C. Neutralizing antibodies in sera fro macaques immunized with attenuated simian immunodeficiency virus. J Virol. 72:1998;6950-6955.
26. Johnson R.P., Glickman R.L., Yang J.Q., Kaur A., Dion J.T., Mulligan M.J., Desrosiers R.C. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian imunodeficiency virus. J Virol. 71:1997;7711-7718.
27. Means R.E., Greenough T., Desrosiers R.C. Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus. J Virol. 71:1997;7895-7902.
28. Schneider J., Kaaden O., Copeland T.D., Oroszlan S., Hunsmann G. Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus. J Gen Virol. 67:1986;2533-2538.
29. Arthur L.O., Bess J. Jr, Sowder R.C, et al. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science. 258:1992;1935-1938.
30. Richieri S.P., Bartholomew R., Aloia R.C., Savary J., Gore R., Holt J., Ferre F., Musil R., Tian H.R., Trauger R., Lowry P., Jensen F., Carlo D.J., Maigetter R.Z., Prior C.P. Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography. Vaccine. 16:1998;119-129.
31. Stott E.J. Anti-cell antibody in macaques. Nature. 353:1991;393.
32. Le Grand R., Vogt G., Vaslin B., Roques P., Theodoro F., Aubertin A.M., Dormont D. Specific and non-specific immunity and protection of macaques against SIV infection. Vaccine. 10:1992;873-879.
33. Goldstein S., Elkins W.R., London W.T., Hahn A., Toeken R., Martin J.E., Hirsch V.M. Immunization with whole inactivated vaccine protects from infection by SIV grown in human but not macaque cells. J Med Primatol. 23:1994;75-82.
34. Klavinskis L.S., Bergmeier L.A., Gao L., Mitchell E., Ward R.G., Layton G., Brookes R., Meyers N.J., Lehner T. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes. J Immunol. 157:1996;2521-2527.
35. + Th1 cells. Vaccine. 13:1995;1741-1749.